A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment. An experimental gene-editing treatment called CTX310 has shown early promise in people whose cholesterol and other blood [...]
A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment.
An experimental gene-editing treatment called CTX310 has shown early promise in people whose cholesterol and other blood [...]
What if one infusion could keep cholesterol down for a year?
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment. An experimental gene-editing treatment called CTX310 has shown early promise in people whose cholesterol and other blood [...] What if one infusion could keep cholesterol down for a year?
What if one infusion could keep cholesterol down for a year?
Open the app view to save this story, compare related coverage, and continue from the same source.